|
80
|
298
|
7yrzA |
Crystal structure of hcov 229e main protease in complex with pf07321332 |
|
89
|
306
|
8aizAAA |
Mpro of sars-cov-2 in complex with the rk-68 inhibitor |
|
86
|
306
|
8aivAAA |
Mpro of sars cov-2 in complex with the mg-100 inhibitor |
|
86
|
304
|
8i30A |
Crystal structure of the sars-cov-2 main protease in complex with 32j |
|
84
|
302
|
8fiwA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun10221 |
|
80
|
301
|
8b56A |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the inhibitor gd-9 |
|
64
|
221
|
8dy8A |
Crystal structure of the r178q mutant of ubiquitin carboxy terminal hydrolase l1 (uch-l1) |
|
86
|
306
|
8tbeA |
Co-crystal structure of sars-cov-2 mpro with pomotrelvir |
|
82
|
305
|
7urbB |
Sars-cov2 main protease in complex with cdd-1733 |
|
80
|
304
|
8frjA |
Structure of nsp14 n7-methyltransferase domain fused with telsam bound to sgc0946 |
|
79
|
299
|
8frkA |
Structure of nsp14 n7-methyltransferase domain fused with telsam bound to sgc8158 |
|
85
|
306
|
7ur9A |
Sars-cov2 main protease in complex with inhibitor cdd-1845 |
|
87
|
302
|
7us4A |
Sars-cov2 main protease in complex with cdd-1819 |
|
0
|
15
|
8cmgC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434 |
|
93
|
317
|
7ybgA |
Crystal structure of the sars-cov-2 papain-like protease (c111s mutant) |
|
80
|
301
|
8gfnA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with bbh1 |
|
86
|
302
|
8gfrA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nbh2 |
|
76
|
258
|
8hblA |
Crystal structure of the sars-unique domain (sud) of sars-cov-2 (1.58 angstrom resolution) |
|
79
|
258
|
8gqcA |
Crystal structure of the sars-unique domain (sud) of sars-cov-2 (1.35 angstrom resolution) |
|
82
|
302
|
8gfkA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304 |
|
83
|
302
|
8gfoA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with gc373 |
|
82
|
302
|
8gfuA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nirmatrelvir (nmv) |
|
94
|
324
|
8bs9A |
Structure of usp36 in complex with ubiquitin-pa |
|
98
|
324
|
8bs3A |
Structure of usp36 in complex with fubi-pa |
|
75
|
305
|
8didA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
304
|
8diiA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
300
|
8digA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
77
|
300
|
8difA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
84
|
305
|
8dieA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
87
|
298
|
8ddlA |
Sars-cov-2 main protease (mpro) h163a mutant apo structure |
|
85
|
304
|
8dibA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
304
|
8dihA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
305
|
8dicA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
79
|
298
|
8husA |
Crystal structure of sars main protease in complex with s217622 |
|
88
|
299
|
8huxA |
Crystal structure of sars-cov-2 main protease p132h mutant in complex with s217622 |
|
84
|
299
|
8hutA |
Crystal structure of mers main protease in complex with s217622 |
|
84
|
297
|
8huwA |
Crystal structure of sars-cov-2 main protease k90r mutant in complex with s217622 |
|
81
|
297
|
8huvA |
Crystal structure of sars-cov-2 main protease g15s mutant in complex with s217622 |
|
84
|
298
|
8huuA |
Crystal structure of hcov-nl63 main protease with s217622 |
|
82
|
298
|
8hurA |
Crystal structure of sars-cov-2 main protease in complex with s217622 |
|
83
|
304
|
8sxoA |
Crystal structure of sars-cov-2 main protease (mpro) h164i mutant |
|
91
|
294
|
8a23A |
Crystal structure of sars-cov-2 nsp10/nsp16 methyltransferase in complex with to383 |
|
27
|
109
|
8a23B |
Crystal structure of sars-cov-2 nsp10/nsp16 methyltransferase in complex with to383 |
|
82
|
348
|
8d34A |
Crystal structure of sars cov-2 nsp15 endroribonuclease h250a |
|
107
|
343
|
7xhkB |
High-resolution x-ray cocrystal structure of usp7 in complex with lx04-46 |
|
88
|
306
|
8skhA |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors |
|
86
|
305
|
8sk4A |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors) |
|
88
|
305
|
8d4pA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun10-90-3-c1 |
|
27
|
116
|
8osxB |
Sars-cov-2 nsp10-16 methyltransferase in complex with atp |
|
96
|
301
|
8osxA |
Sars-cov-2 nsp10-16 methyltransferase in complex with atp |
